Tower Research Capital LLC (Trc) Equillium, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Equillium, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,963 shares of EQ stock, worth $4,591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,963Holding current value
$4,591% of portfolio
0.0%Shares
23 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.3MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$3.42 Million0.71% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$3.42 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$648,2990.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$432,954100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny261KShares$201,2780.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $26.5M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...